Correlation Between Galectin-3, RDW, Hepc, HS and Ferritin and Prognosis of Patients with Acute Onset of Chronic Heart Failure

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2022 Nov 8

PMID 36348283

Authors

Lingling Yao

Yanjie Tan

Fei Chen

Affiliations

Soon will be listed here.

Abstract

Background: Chronic heart failure (CHF) is characterized by a high hospitalization rate and a high mortality rate. It is particularly important to identify biomarkers for predicting the prognosis of patients with acute attack of CHF.

Purpose: To observe the correlation between galectin-3, RDW, Hepc, HS and ferritin and the prognosis of patients with acute onset of CHF.

Methods: The study included 92 patients with acute onset of CHF who received treatment at our hospital between August 2020 and December 2021. After treatment, the patients were divided into the effective group and the non-effective group based on the effectiveness of treatment. The levels of galectin-3, RDW, Hepc, HS and ferritin before and after treatment were compared between the two groups and the correlation between prognosis of patients with acute attack of CHF and galectin-3, RDW, Hepc, HS and ferritin was observed.

Results: The effective rate was 71.74% (66/92) and the ineffective rate was 28.26% (26/92) in the 92 patients with acute attack of CHF in the study. Before and after treatment, the levels of galectin-3, RDW, Hepc, and HS were lower in the effective group than those of the non-effective group while the level of ferritin was higher in the effective group than that of the non-effective group (P < 0.05). Spearman correlation analysis showed that the level of prognosis of patients with acute attack of CHF was positively correlated with galectin-3, RDW, Hepc, and HS (r = 0.217, 0.109, 0.376, 0.765, P = 0.026, 0.032, 0.021, 0.006), and negatively correlated with ferritin (r = - 0.127, P = 0.037). The independent variables were galectin-3, RDW, Hepc, HS and ferritin and the dependent variable was prognosis of patients with acute attack of CHF. Univariate logistic regression analysis showed that alectin-3, RDW, Hepc, HS, and ferritin were protective factors for the prognosis of patients with acute attack of CHF. The independent variables were galectin-3, RDW, Hepc, HS and ferritin, dependent variables and the dependent variable was prognosis of patients with acute attack of CHF. Multivariate logistic regression analysis revealed that galectin-3, RDW, and Hepc were risk factors of the prognosis of patients with acute attack of CHF.

Conclusion: Galectin-3, RDW, Hepc, HS and ferritin were closely related with the prognosis of patients with acute attack of CHF and galectin-3, RDW, and Hepc were risk factors of the prognosis of patients with acute attack of CHF.

Citing Articles

The long-term impact of increased red blood cell distribution width detected during hospitalization for heart failure.

Mayer O, Bruthans J, Jirak J, Filipovsky J Biomark Med. 2024; 18(19):831-842.

PMID: 39254358 PMC: 11497996. DOI: 10.1080/17520363.2024.2395237.

The Role of Galectin-3 in Heart Failure-The Diagnostic, Prognostic and Therapeutic Potential-Where Do We Stand?.

Zaborska B, Sikora-Frac M, Smarz K, Pilichowska-Paszkiet E, Budaj A, Sitkiewicz D Int J Mol Sci. 2023; 24(17).

PMID: 37685918 PMC: 10488150. DOI: 10.3390/ijms241713111.

Diagnostic value of procalcitonin and red blood cell distribution width at admission on the prognosis of patients with severe burns: A retrospective analysis.

Tang X, Qiu L, Wang F, Liu S, Lu X, Chen X Int Wound J. 2023; 20(9):3708-3716.

PMID: 37381890 PMC: 10588303. DOI: 10.1111/iwj.14263.

Red Blood Cell Distribution Width: A Risk Factor for Prognosis in Patients with Ischemic Cardiomyopathy after Percutaneous Coronary Intervention.

Zhang B, Xu Y, Huang X, Sun T, Ma M, Chen Z J Clin Med. 2023; 12(4).

PMID: 36836116 PMC: 9964585. DOI: 10.3390/jcm12041584.

References

Ashitha B, Rangaswamy . Relationship between Red Cell Distribution Width and Heart Failure. J Assoc Physicians India. 2020; 68(1):53. View

Liu C, Li R, Liu Y, Li Z, Sun Y, Yin P . Characteristics of Blood Metabolic Profile in Coronary Heart Disease, Dilated Cardiomyopathy and Valvular Heart Disease Induced Heart Failure. Front Cardiovasc Med. 2021; 7:622236. PMC: 7856915. DOI: 10.3389/fcvm.2020.622236. View

Ptaszynska-Kopczynska K, Eljaszewicz A, Marcinkiewicz-Siemion M, Sawicka-Smiarowska E, Tarasiuk E, Lisowska A . Monocyte Subsets in Patients with Chronic Heart Failure Treated with Cardiac Resynchronization Therapy. Cells. 2021; 10(12). PMC: 8700101. DOI: 10.3390/cells10123482. View

Walther C, Triozzi J, Deswal A . Iron deficiency and iron therapy in heart failure and chronic kidney disease. Curr Opin Nephrol Hypertens. 2020; 29(5):508-514. DOI: 10.1097/MNH.0000000000000630. View

Chen H, Chen C, Fang J, Wang R, Nie W . Circulating galectin-3 on admission and prognosis in acute heart failure patients: a meta-analysis. Heart Fail Rev. 2019; 25(2):331-341. DOI: 10.1007/s10741-019-09858-2. View

Slivnick J, Lampert B . Hypertension and Heart Failure. Heart Fail Clin. 2019; 15(4):531-541. DOI: 10.1016/j.hfc.2019.06.007. View

. [Chinese guidelines for the diagnosis and treatment of heart failure 2018]. Zhonghua Xin Xue Guan Bing Za Zhi. 2018; 46(10):760-789. DOI: 10.3760/cma.j.issn.0253-3758.2018.10.004. View

Di Palo K, Barone N . Hypertension and Heart Failure: Prevention, Targets, and Treatment. Heart Fail Clin. 2019; 16(1):99-106. DOI: 10.1016/j.hfc.2019.09.001. View

Bechthold A, Boeing H, Schwedhelm C, Hoffmann G, Knuppel S, Iqbal K . Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies. Crit Rev Food Sci Nutr. 2017; 59(7):1071-1090. DOI: 10.1080/10408398.2017.1392288. View

10.

Merle U, Fein E, Gehrke S, Stremmel W, Kulaksiz H . The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology. 2007; 148(6):2663-8. DOI: 10.1210/en.2006-1331. View

11.

Tona F, Montisci R, Iop L, Civieri G . Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction. Rev Cardiovasc Med. 2021; 22(1):97-104. DOI: 10.31083/j.rcm.2021.01.277. View

12.

Haynes R, Zhu D, Judge P, Herrington W, Kalra P, Baigent C . Chronic kidney disease, heart failure and neprilysin inhibition. Nephrol Dial Transplant. 2019; 35(4):558-564. PMC: 7139204. DOI: 10.1093/ndt/gfz058. View

13.

Martinez-Quintana E, Estupinan-Leon H, Riano-Ruiz M, Rodriguez-Gonzalez F, Tugores A . Red blood cell distribution width in addition to N-terminal prohormone of B-type natriuretic peptide concentration improves assessment of risk of cardiovascular events in adult patients with congenital heart disease. Arch Cardiovasc Dis. 2020; 113(10):607-616. DOI: 10.1016/j.acvd.2020.05.019. View

14.

Ponikowski P, Kirwan B, Anker S, McDonagh T, Dorobantu M, Drozdz J . Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020; 396(10266):1895-1904. DOI: 10.1016/S0140-6736(20)32339-4. View

15.

Ksiazczyk M, Lelonek M . Angiotensin receptor/neprilysin inhibitor-a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings. Heart Fail Rev. 2019; 25(3):393-402. PMC: 7181555. DOI: 10.1007/s10741-019-09879-x. View

16.

Hanna A, Frangogiannis N . Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure. Cardiovasc Drugs Ther. 2020; 34(6):849-863. PMC: 7479403. DOI: 10.1007/s10557-020-07071-0. View

17.

Escaned J, Lerman L . Coronary microcirculation and hypertensive heart failure. Eur Heart J. 2020; 41(25):2376-2378. DOI: 10.1093/eurheartj/ehaa437. View

18.

Alnuwaysir R, Hoes M, Van Veldhuisen D, van der Meer P, Grote Beverborg N . Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology. J Clin Med. 2022; 11(1). PMC: 8745653. DOI: 10.3390/jcm11010125. View

19.

Mikkelsen L, Nordestgaard B, Schnohr P, Ellervik C . Increased Ferritin Concentration and Risk of Atrial Fibrillation and Heart Failure in Men and Women: Three Studies of the Danish General Population Including 35799 Individuals. Clin Chem. 2018; 65(1):180-188. DOI: 10.1373/clinchem.2018.292763. View

20.

Thandavarayan R, Chitturi K, Guha A . Pathophysiology of Acute and Chronic Right Heart Failure. Cardiol Clin. 2020; 38(2):149-160. DOI: 10.1016/j.ccl.2020.01.009. View